NEXT GENERATION IMMUNO-ONCOLOGY

Illuminating non-responsive tumours for attack and destruction

Discover More

OUR SCIENCE

DEVELOPING NEXT GENERATION IMMUNOTHERAPIES THAT ILLUMINATE NON-RESPONSIVE TUMOURS FOR DESTRUCTION BY THE IMMUNE SYSTEM.

Current immunotherapy approaches target the minority of tumours that are visible to the immune system. By targeting the ERAP proteases in the antigen presentation pathway Grey Wolf aims to change the neoantigen repertoire in cancer, increasing tumour visibility and extending the therapeutic benefit of immunotherapy to many more cancer patients.

Find out more >

SITC Poster

Register your interest to receive a copy of Grey Wolf's e-poster from SITC 2020.

Latest News

PROUDLY AWARDED